Status:
COMPLETED
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with ...
Eligibility Criteria
Inclusion
- Male or female patients older than 18 years
- With a diagnosis of schizophrenia (DSM-IV TR criteria)
- Stabilized out-patients
- Under oral antipsychotic monotherapy
Exclusion
- Administration of a depot antipsychotic drug
- Suicide risk
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT00873249
Start Date
April 1 2009
End Date
March 1 2010
Last Update
March 24 2010
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alicante, Alicante, Spain
2
Research Site
Almería, Almeria, Spain
3
Research Site
Barcelona, Barcelona, Spain
4
Research Site
Berga, Barcelona, Spain